Collectively, our study bridges a critical knowledge gap by presenting the first pan‐cancer, immune‐centric exploration of DHCR7, unveiling its dual function as a metabolic regulator and immunomodulator with potential therapeutic implications. This evidence concerns the gene DHCR7 and cancer.